Skip To The Main Content
Other PDA Sites
PDA Letter
PDA Journal
PDA Connect
PDA Technical Report Portal
Get Involved
Become a Volunteer
Volunteer Opportunities
Join / Login
Login to Your PDA Account
Sign in
Don't have an account yet?
Create an Account
Forgot your username or password?
Recover account
Parenteral Drug Association
Connecting People, Science and Regulation
®
Parenteral Drug Association
Connecting People, Science and Regulation
®
Home
Events
Training
Topic Areas
Aseptic Processing & Sterilization
Biopharmaceuticals & Biotechnology
Manufacturing Science
Quality & Regulatory
Supply Chain & Outsourcing
Publications
Bookstore
PDA Journal
PDA Letter
Technical Reports
Global Community
Chapters
Interest Groups
Membership Directory
Member Resources
PDA Connect
Standards
Volunteer Opportunities
Technical Advisory Boards
Foundation
Join PDA
Attendee Presentations
2017 PDA Endotoxins Workshop
Program Agenda
Program Agenda
(?)
Jack Levin, MD - Presentation Not Authorized for Distribution
P1: Opening Plenary: Academic Perspectives on the Limulus Amebocyte Lysate Assay, Endotoxin Structure, and Diversity
(?)
M. Stephen Trent, PhD - Presentation Not Authorized for Distribution
P1: Opening Plenary: Academic Perspectives on the Limulus Amebocyte Lysate Assay, Endotoxin Structure, and Diversity
(?)
Maria “Reyes” Candau-Chacon, PhD
P2: Practical Issues with Endotoxin Testing and Regulatory Responsibilities of Sponsors
(?)
Amber Dellar
P2: Practical Issues with Endotoxin Testing and Regulatory Responsibilities of Sponsors
(?)
John A. Dubczak
P2: Practical Issues with Endotoxin Testing and Regulatory Responsibilities of Sponsors
(?)
Douglas W. Stearn, JD
Breakfast Session: Data Integrity
(?)
Malcolm A. Finkelman, PhD
P3: Beta-Glucans: Practical Issues Associated with Pharmaceutical Manufacturing, Effects on Bacterial Endotoxin Testing, and Potential Impact on Patient Safety
(?)
Christine Schubert, PhD
P3: Beta-Glucans: Practical Issues Associated with Pharmaceutical Manufacturing, Effects on Bacterial Endotoxin Testing, and Potential Impact on Patient Safety
(?)
Jay Bolden
Group A – Case Study 1: Setting Endotoxin Specifications
(?)
Friedrich von Wintzingerode, PhD
Group B – Case Study 2: Setting in-Process Endotoxin Limits
(?)
Ned M. Mozier, PhD
Small Group Discussion: Pyrogen Test Comparison
(?)
Ingo Spreitzer - UPDATED
Small Group Discussion: Pyrogen Test Comparison
(?)
Small Group Discussion Questions
Small Group Discussion: Pyrogen Test Comparison
(?)
John A. Dubczak
P4: BET Laboratories: Practical Advice
(?)
Veronika Wills, MSc
P4: BET Laboratories: Practical Advice
(?)
Login to Your PDA Account
Sign In
Signing In
Don't have an account yet?
Create an Account
Forgot your username or password?
Recover account